Tapewire

Nasdaq · USD

MPLT

MapLight Therapeutics, Inc.

Export transactions ↓
Tapewire entity
5316
SEC CIK
0001770069
Parsed reports
94

Last 12 months

Inside the activity.

10 purchase rows · 139 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202604
Feb 202649
Mar 202600
Apr 2026026
May 2026054
Jun 202600
Jul 2026544
Aug 202611
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 15, 2026 Filed Jul 18, 2026 01:43 UTC
Foff Erin PennockChief Medical Officer
SaleVoting Common Stock 8,972 $36.99 $331,874.28
Disclosure

SEC source: 0002021233-26-000012 · form4-07182026_010714.xml · nonDerivative · entry 4

Foff Erin Pennock · CIK 0002021233 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 317,622

F4 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.53 to $37.405 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 15, 2026 Filed Jul 18, 2026 01:43 UTC
Foff Erin PennockChief Medical Officer
SaleVoting Common Stock 4,465 $36.00 $160,740.00
Disclosure

SEC source: 0002021233-26-000012 · form4-07182026_010714.xml · nonDerivative · entry 3

Foff Erin Pennock · CIK 0002021233 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 326,594

F4 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.5338 to $36.5273 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 15, 2026 Filed Jul 18, 2026 01:43 UTC
Foff Erin PennockChief Medical Officer
SaleVoting Common Stock 7,845 $37.04 $290,578.80
Disclosure

SEC source: 0002021233-26-000012 · form4-07182026_010714.xml · nonDerivative · entry 2

Foff Erin Pennock · CIK 0002021233 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 331,059

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.701 to $37.54 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 15, 2026 Filed Jul 18, 2026 01:43 UTC
Foff Erin PennockChief Medical Officer
SaleVoting Common Stock 7,155 $36.16 $258,724.80
Disclosure

SEC source: 0002021233-26-000012 · form4-07182026_010714.xml · nonDerivative · entry 1

Foff Erin Pennock · CIK 0002021233 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 338,904

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.70 to $36.685 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 15, 2026 Filed Jul 18, 2026 01:46 UTC
Kroeger Christopher A.Director · Chief Executive Officer
SaleVoting Common Stock 90 $37.54 $3,378.60
Disclosure

SEC source: 0001658918-26-000014 · form4-07182026_010744.xml · nonDerivative · entry 3

Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,332,316

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

Read SEC document
July 15, 2026 Filed Jul 18, 2026 01:46 UTC
Kroeger Christopher A.Director · Chief Executive Officer
SaleVoting Common Stock 42,738 $36.99 $1,580,878.62
Disclosure

SEC source: 0001658918-26-000014 · form4-07182026_010744.xml · nonDerivative · entry 2

Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,332,406

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.53 to $37.405 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 15, 2026 Filed Jul 18, 2026 01:46 UTC
Kroeger Christopher A.Director · Chief Executive Officer
SaleVoting Common Stock 18,950 $36.00 $682,200.00
Disclosure

SEC source: 0001658918-26-000014 · form4-07182026_010744.xml · nonDerivative · entry 1

Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,375,144

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.5338 to $36.5273 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 15, 2026 Filed Jul 18, 2026 01:45 UTC
Lillie James WoodruffChief Scientific Officer
SaleVoting Common Stock 12 $37.54 $450.48
Disclosure

SEC source: 0001728746-26-000012 · form4-07182026_010728.xml · nonDerivative · entry 3

Lillie James Woodruff · CIK 0001728746 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 235,086

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

Read SEC document
July 15, 2026 Filed Jul 18, 2026 01:45 UTC
Lillie James WoodruffChief Scientific Officer
SaleVoting Common Stock 5,393 $36.99 $199,487.07
Disclosure

SEC source: 0001728746-26-000012 · form4-07182026_010728.xml · nonDerivative · entry 2

Lillie James Woodruff · CIK 0001728746 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 235,098

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.53 to $37.405 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 15, 2026 Filed Jul 18, 2026 01:45 UTC
Lillie James WoodruffChief Scientific Officer
SaleVoting Common Stock 2,238 $36.00 $80,568.00
Disclosure

SEC source: 0001728746-26-000012 · form4-07182026_010728.xml · nonDerivative · entry 1

Lillie James Woodruff · CIK 0001728746 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 240,491

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.5338 to $36.5251 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 15, 2026 Filed Jul 18, 2026 01:44 UTC
Hanson KristopherGeneral Counsel
SaleVoting Common Stock 10 $37.54 $375.40
Disclosure

SEC source: 0001789970-26-000012 · form4-07182026_010724.xml · nonDerivative · entry 3

Hanson Kristopher · CIK 0001789970 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 155,071

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

Read SEC document
July 15, 2026 Filed Jul 18, 2026 01:44 UTC
Hanson KristopherGeneral Counsel
SaleVoting Common Stock 5,103 $36.99 $188,759.97
Disclosure

SEC source: 0001789970-26-000012 · form4-07182026_010724.xml · nonDerivative · entry 2

Hanson Kristopher · CIK 0001789970 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 155,081

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.53 to $37.405 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 15, 2026 Filed Jul 18, 2026 01:44 UTC
Hanson KristopherGeneral Counsel
SaleVoting Common Stock 2,147 $36.00 $77,292.00
Disclosure

SEC source: 0001789970-26-000012 · form4-07182026_010724.xml · nonDerivative · entry 1

Hanson Kristopher · CIK 0001789970 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,184

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.5338 to $36.5273 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 15, 2026 Filed Jul 20, 2026 10:00 UTC
Kreitzer AnatolChief Discovery Officer
SaleVoting Common Stock 4,510 $36.94 $166,599.40
Disclosure

SEC source: 0002021238-26-000010 · form4-07202026_060701.xml · nonDerivative · entry 2

Kreitzer Anatol · CIK 0002021238 · Chief Discovery Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 201,135

F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.68 to $37.325 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 15, 2026 Filed Jul 20, 2026 10:00 UTC
Kreitzer AnatolChief Discovery Officer
SaleVoting Common Stock 5,545 $36.13 $200,340.85
Disclosure

SEC source: 0002021238-26-000010 · form4-07202026_060701.xml · nonDerivative · entry 1

Kreitzer Anatol · CIK 0002021238 · Chief Discovery Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 205,645

F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.68 to $36.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 15, 2026 Filed Jul 20, 2026 10:00 UTC
GILLIS JONATHANCAO and Interim CFO
SaleVoting Common Stock 4,699 $36.94 $173,581.06
Disclosure

SEC source: 0001709954-26-000010 · form4-07202026_060704.xml · nonDerivative · entry 2

GILLIS JONATHAN · CIK 0001709954 · CAO and Interim CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 171,164

F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.68 to $37.325 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 15, 2026 Filed Jul 20, 2026 10:00 UTC
GILLIS JONATHANCAO and Interim CFO
SaleVoting Common Stock 5,356 $36.13 $193,512.28
Disclosure

SEC source: 0001709954-26-000010 · form4-07202026_060704.xml · nonDerivative · entry 1

GILLIS JONATHAN · CIK 0001709954 · CAO and Interim CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 175,863

F1 · kind: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F1 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.68 to $36.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 23, 2026 Filed Jun 25, 2026 21:59 UTC GrantStock Option (right to buy) · Derivative 14,902 $0.00 Strike: $28.64 $0.00
Disclosure

SEC source: 0001998937-26-000004 · form4-06252026_090607.xml · derivative · entry 3

Garnett Timothy John · CIK 0001998937 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,902

Underlying: Voting Common Stock · 14,902 shares

Expires 2036-06-22

F4 · derivative.exercise_date: Represents a stock option granted pursuant to the Plan. The shares subject to this stock option will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.

Read SEC document
June 23, 2026 Filed Jun 25, 2026 21:59 UTC GrantVoting Common Stock 3,932 $0.00 $0.00
Disclosure

SEC source: 0001998937-26-000004 · form4-06252026_090607.xml · nonDerivative · entry 1

Garnett Timothy John · CIK 0001998937 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,457

F1 · shares: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan"). The RSUs will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.

F2 · price: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.

Read SEC document
June 23, 2026 Filed Jun 25, 2026 21:57 UTC GrantStock Option (right to buy) · Derivative 14,902 $0.00 Strike: $28.64 $0.00
Disclosure

SEC source: 0002089511-26-000002 · form4-06252026_090604.xml · derivative · entry 2

Luneborg Nanna Liebach · CIK 0002089511 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,902

Underlying: Voting Common Stock · 14,902 shares

Expires 2036-06-22

F3 · derivative.exercise_date: Represents a stock option granted pursuant to the Plan. The shares subject to this stock option will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.

Read SEC document
June 23, 2026 Filed Jun 25, 2026 21:57 UTC GrantVoting Common Stock 3,932 $0.00 $0.00
Disclosure

SEC source: 0002089511-26-000002 · form4-06252026_090604.xml · nonDerivative · entry 1

Luneborg Nanna Liebach · CIK 0002089511 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,932

F1 · shares: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan"). The RSUs will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.

F2 · price: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.

Read SEC document
June 23, 2026 Filed Jun 25, 2026 21:54 UTC GrantStock Option (right to buy) · Derivative 14,902 $0.00 Strike: $28.64 $0.00
Disclosure

SEC source: 0001470798-26-000004 · form4-06252026_090639.xml · derivative · entry 2

Pavlov George · CIK 0001470798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,902

Underlying: Voting Common Stock · 14,902 shares

Expires 2036-06-22

F3 · derivative.exercise_date: Represents a stock option granted pursuant to the Plan. The shares subject to this stock option will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.

Read SEC document
June 23, 2026 Filed Jun 25, 2026 21:54 UTC GrantVoting Common Stock 3,932 $0.00 $0.00
Disclosure

SEC source: 0001470798-26-000004 · form4-06252026_090639.xml · nonDerivative · entry 1

Pavlov George · CIK 0001470798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,932

F1 · shares: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan"). The RSUs will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.

F2 · price: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.

Read SEC document
June 23, 2026 Filed Jun 25, 2026 22:01 UTC GrantStock Option (right to buy) · Derivative 29,804 $0.00 Strike: $28.64 $0.00
Disclosure

SEC source: 0001435618-26-000011 · form4-06252026_100631.xml · derivative · entry 2

Babler Martin · CIK 0001435618 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,804

Underlying: Voting Common Stock · 29,804 shares

Expires 2036-06-22

F3 · derivative.exercise_date: Represents a stock option granted pursuant to the Plan. The shares subject to this stock option will vest in three equal annual installments beginning on June 23, 2027, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.

Read SEC document
June 23, 2026 Filed Jun 25, 2026 22:01 UTC GrantVoting Common Stock 7,864 $0.00 $0.00
Disclosure

SEC source: 0001435618-26-000011 · form4-06252026_100631.xml · nonDerivative · entry 1

Babler Martin · CIK 0001435618 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,864

F1 · shares: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan"). The RSUs will vest in three equal annual installments beginning on June 23, 2027, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.

F2 · price: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.

Read SEC document
June 23, 2026 Filed Jun 25, 2026 22:04 UTC
Cox TroyDirector
GrantStock Option (right to buy) · Derivative 29,804 $0.00 Strike: $28.64 $0.00
Disclosure

SEC source: 0001696923-26-000005 · form4-06252026_100620.xml · derivative · entry 2

Cox Troy · CIK 0001696923 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,804

Underlying: Voting Common Stock · 29,804 shares

Expires 2036-06-22

F3 · derivative.exercise_date: Represents a stock option granted pursuant to the Plan. The shares subject to this stock option will vest in three equal annual installments beginning on June 23, 2027, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.

Read SEC document
June 23, 2026 Filed Jun 25, 2026 22:04 UTC
Cox TroyDirector
GrantVoting Common Stock 7,864 $0.00 $0.00
Disclosure

SEC source: 0001696923-26-000005 · form4-06252026_100620.xml · nonDerivative · entry 1

Cox Troy · CIK 0001696923 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,864

F1 · shares: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan"). The RSUs will vest in three equal annual installments beginning on June 23, 2027, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.

F2 · price: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.

Read SEC document
June 23, 2026 Filed Jun 25, 2026 21:52 UTC GrantStock Option (right to buy) · Derivative 14,902 $0.00 Strike: $28.64 $0.00
Disclosure

SEC source: 0001826519-26-000002 · form4-06252026_090603.xml · derivative · entry 2

Walker Maria C · CIK 0001826519 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,902

Underlying: Voting Common Stock · 14,902 shares

Expires 2036-06-22

F3 · derivative.exercise_date: Represents a stock option granted pursuant to the Plan. The shares subject to this stock option will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.

Read SEC document
June 23, 2026 Filed Jun 25, 2026 21:52 UTC GrantVoting Common Stock 3,932 $0.00 $0.00
Disclosure

SEC source: 0001826519-26-000002 · form4-06252026_090603.xml · nonDerivative · entry 1

Walker Maria C · CIK 0001826519 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,703

F1 · shares: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan"). The RSUs will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.

F2 · price: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.

Read SEC document
May 18, 2026 Filed May 19, 2026 01:27 UTC
Kroeger Christopher A.Director · Chief Executive Officer
SaleVoting Common Stock 198 $28.15 $5,573.70
Disclosure

SEC source: 0001658918-26-000012 · form4-05192026_010517.xml · nonDerivative · entry 2

Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,394,094

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.57 to $28.20 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 18, 2026 Filed May 19, 2026 01:27 UTC
Kroeger Christopher A.Director · Chief Executive Officer
SaleVoting Common Stock 118,037 $27.19 $3,209,426.03
Disclosure

SEC source: 0001658918-26-000012 · form4-05192026_010517.xml · nonDerivative · entry 1

Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,394,292

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.565 to $27.4347 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 11, 2026 Filed May 12, 2026 01:30 UTC
Kroeger Christopher A.Director · Chief Executive Officer
SaleVoting Common Stock 5,890 $30.56 $179,998.40
Disclosure

SEC source: 0001658918-26-000010 · form4-05112026_090504.xml · nonDerivative · entry 9

Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,512,329

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.305 to $30.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 11, 2026 Filed May 12, 2026 01:30 UTC
Kroeger Christopher A.Director · Chief Executive Officer
SaleVoting Common Stock 6,871 $30.04 $206,404.84
Disclosure

SEC source: 0001658918-26-000010 · form4-05112026_090504.xml · nonDerivative · entry 8

Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,518,219

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.305 to $30.3045 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 11, 2026 Filed May 12, 2026 01:30 UTC
Kroeger Christopher A.Director · Chief Executive Officer
SaleVoting Common Stock 877 $28.70 $25,169.90
Disclosure

SEC source: 0001658918-26-000010 · form4-05112026_090504.xml · nonDerivative · entry 7

Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,525,090

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.30 to $29.183 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 11, 2026 Filed May 12, 2026 01:30 UTC
Kroeger Christopher A.Director · Chief Executive Officer
SaleVoting Common Stock 342 $27.57 $9,428.94
Disclosure

SEC source: 0001658918-26-000010 · form4-05112026_090504.xml · nonDerivative · entry 6

Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,525,967

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.26 to $28.08 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 11, 2026 Filed May 12, 2026 01:30 UTC
Hanson KristopherGeneral Counsel
SaleVoting Common Stock 5,808 $30.56 $177,492.48
Disclosure

SEC source: 0001789970-26-000010 · form4-05112026_090506.xml · nonDerivative · entry 4

Hanson Kristopher · CIK 0001789970 · General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 162,331

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.305 to $30.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 11, 2026 Filed May 12, 2026 01:30 UTC
Hanson KristopherGeneral Counsel
SaleVoting Common Stock 6,979 $30.04 $209,649.16
Disclosure

SEC source: 0001789970-26-000010 · form4-05112026_090506.xml · nonDerivative · entry 3

Hanson Kristopher · CIK 0001789970 · General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 168,139

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.305 to $30.2965 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 11, 2026 Filed May 12, 2026 01:30 UTC
Hanson KristopherGeneral Counsel
SaleVoting Common Stock 846 $28.70 $24,280.20
Disclosure

SEC source: 0001789970-26-000010 · form4-05112026_090506.xml · nonDerivative · entry 2

Hanson Kristopher · CIK 0001789970 · General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 175,118

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.30 to $29.183 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 11, 2026 Filed May 12, 2026 01:30 UTC
Hanson KristopherGeneral Counsel
SaleVoting Common Stock 284 $27.61 $7,841.24
Disclosure

SEC source: 0001789970-26-000010 · form4-05112026_090506.xml · nonDerivative · entry 1

Hanson Kristopher · CIK 0001789970 · General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 175,964

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.26 to $28.08 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 08, 2026 Filed May 12, 2026 01:30 UTC
Kroeger Christopher A.Director · Chief Executive Officer
SaleVoting Common Stock 3,205 $29.20 $93,586.00
Disclosure

SEC source: 0001658918-26-000010 · form4-05112026_090504.xml · nonDerivative · entry 5

Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,526,309

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.12 to $29.49 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 08, 2026 Filed May 12, 2026 01:30 UTC
Kroeger Christopher A.Director · Chief Executive Officer
SaleVoting Common Stock 1,582 $28.56 $45,181.92
Disclosure

SEC source: 0001658918-26-000010 · form4-05112026_090504.xml · nonDerivative · entry 4

Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,529,514

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.11 to $29.09 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 08, 2026 Filed May 12, 2026 01:30 UTC
Kroeger Christopher A.Director · Chief Executive Officer
SaleVoting Common Stock 29,624 $27.48 $814,067.52
Disclosure

SEC source: 0001658918-26-000010 · form4-05112026_090504.xml · nonDerivative · entry 3

Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,531,096

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.11 to $28.1099 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 07, 2026 Filed May 12, 2026 01:30 UTC
Foff Erin PennockChief Medical Officer
SaleVoting Common Stock 117 $29.10 $3,404.70
Disclosure

SEC source: 0002021233-26-000010 · form4-05112026_090503.xml · nonDerivative · entry 2

Foff Erin Pennock · CIK 0002021233 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 346,059

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.09 to $29.10 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 07, 2026 Filed May 12, 2026 01:30 UTC
Foff Erin PennockChief Medical Officer
SaleVoting Common Stock 4,321 $28.52 $123,234.92
Disclosure

SEC source: 0002021233-26-000010 · form4-05112026_090503.xml · nonDerivative · entry 1

Foff Erin Pennock · CIK 0002021233 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 346,176

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.08 to $29.045 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 07, 2026 Filed May 12, 2026 01:30 UTC
Kroeger Christopher A.Director · Chief Executive Officer
SaleVoting Common Stock 5,220 $29.15 $152,163.00
Disclosure

SEC source: 0001658918-26-000010 · form4-05112026_090504.xml · nonDerivative · entry 2

Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,560,720

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.91 to $29.325 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 07, 2026 Filed May 12, 2026 01:30 UTC
Kroeger Christopher A.Director · Chief Executive Officer
SaleVoting Common Stock 14,880 $28.47 $423,633.60
Disclosure

SEC source: 0001658918-26-000010 · form4-05112026_090504.xml · nonDerivative · entry 1

Kroeger Christopher A. · CIK 0001658918 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,565,940

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.885 to $28.8833 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 07, 2026 Filed May 12, 2026 01:30 UTC
Lillie James WoodruffChief Scientific Officer
SaleVoting Common Stock 721 $28.28 $20,389.88
Disclosure

SEC source: 0001728746-26-000010 · form4-05112026_090501.xml · nonDerivative · entry 1

Lillie James Woodruff · CIK 0001728746 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 242,729

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.08 to $28.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 06, 2026 Filed May 7, 2026 00:15 UTC
Setia VishwasChief Financial Officer
SaleVoting Common Stock 2,068 $29.07 $60,116.76
Disclosure

SEC source: 0002021256-26-000008 · form4-05062026_080509.xml · nonDerivative · entry 8

Setia Vishwas · CIK 0002021256 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 356,256

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.73 to $29.35 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 06, 2026 Filed May 7, 2026 00:15 UTC
Setia VishwasChief Financial Officer
SaleVoting Common Stock 8,496 $28.04 $238,227.84
Disclosure

SEC source: 0002021256-26-000008 · form4-05062026_080509.xml · nonDerivative · entry 7

Setia Vishwas · CIK 0002021256 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 358,324

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.675 to $28.6587 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 06, 2026 Filed May 7, 2026 00:15 UTC
Foff Erin PennockChief Medical Officer
SaleVoting Common Stock 15,900 $29.13 $463,167.00
Disclosure

SEC source: 0002021233-26-000008 · form4-05062026_080507.xml · nonDerivative · entry 8

Foff Erin Pennock · CIK 0002021233 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 350,497

F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.71 to $29.57 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.